Readnour Robin Shane
Corporate insiderDirectorOpen-market Form 4 activity · 17 Aug 2026 – 8 Sept 2026
Transactions
4
0 buys · 4 sells
Bought
$0
Open-market purchases
Sold
$273K
Open-market sales
★ Trade spotlightANTXAN2 Therapeutics, Inc.The latest-traded stock and its 1Y chart are free All transactions
4 trades in the recent window · 1 grouped rows▸ANTXAN2 Therapeutics, Inc. 4 trades · latest 8 Sept 2026— / $273K